LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Ehsan Sadri, MD, FACS, talks about how to integrate Tecnis multifocal low-add IOL platforms (Abbott Medical Optics) into everyday practice, emphasizing that patient education about IOL choices and expectations results in greater patient satisfaction.
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Rohit Varma, MD, MPH, discusses positive 1-year study results of the minimally invasive Xen gel stent (Aquesys/Allergan) to reduce IOP in patients with elevated pressure.
LAS VEGAS — Zepto is an “innovative disposable device” that utilizes “precision pulsed technology” to create capsulotomies and shows promise in adoption by cataract surgeons when it comes to market, according to the company’s senior executive.John Hendrick, president and CEO of Mynosys Cellular Devices, told colleagues at the Ophthalmology Innovation Summit here that “for many months and years,” the company has been focusing on being able to create “a perfectly round capsulotomy, every time.”
(MedPage Today) — Hospitals could do much more to prevent errors
LAS VEGAS — Early data from study of orally administered X-82 show promise for treating wet age-related macular degeneration, according to a presentation here. X-82 (Tyrogenex) is a tyrosine kinase inhibitor (TKI) with both anti-VEGF and anti- platelet-derived growth factor (PDGF) activities.
Tyrogenex, a privately held company focused on the development of targeted therapeutics for cancer and ophthalmology, today announced data from its phase 1 open-label study of orally-administered X-82 in patients for wet age-related macular degeneratio…